UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

The New England journal of medicine, 2017-02, Vol.376 (5), p.429-439

2017

Volltextzugriff (PDF)

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

The New England journal of medicine, 2019-08, Vol.381 (6), p.509-519

2019

Volltextzugriff (PDF)

Pathophysiology and treatment of pulmonary hypertension in sickle cell disease

Blood, 2016-02, Vol.127 (7), p.820-828

2016

Volltextzugriff (PDF)

Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis

Haematologica (Roma), 2019-04, Vol.104 (4), p.653-658

2019

Volltextzugriff (PDF)

Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis

PloS one, 2020-04, Vol.15 (4), p.e0229959-e0229959

2020

Volltextzugriff (PDF)

Erythrocytic ferroportin reduces intracellular iron accumulation, hemolysis, and malaria risk

Science (American Association for the Advancement of Science), 2018-03, Vol.359 (6383), p.1520-1523

2018

Volltextzugriff (PDF)

Prevalence of iron deficiency in 62,685 women of seven race/ethnicity groups: The HEIRS Study

PloS one, 2020-04, Vol.15 (4), p.e0232125-e0232125

2020

Volltextzugriff (PDF)

The Effect of the Host's Iron Status on Tuberculosis

The Journal of infectious diseases, 2007-06, Vol.195 (12), p.1745-1753

2007

Volltextzugriff (PDF)

An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease

American journal of respiratory and critical care medicine, 2014-03, Vol.189 (6), p.727-740

2014

Volltextzugriff (PDF)

Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease

PloS one, 2020-02, Vol.15 (2), p.e0229710-e0229710

2020

Volltextzugriff (PDF)

Glad tidings and joy for children with SCA

Blood, 2024-04, Vol.143 (14), p.1326-1327

Gordeuk, Victor R

2024

Volltextzugriff (PDF)

Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom

PloS one, 2014-07, Vol.9 (7), p.e99489-e99489

2014

Volltextzugriff (PDF)

Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia

Haematologica (Roma), 2024-05

2024

Volltextzugriff (PDF)

Thrombotic risk in congenital erythrocytosis due to up-regulated hypoxia sensing is not associated with elevated hematocrit

Haematologica (Roma), 2020-03, Vol.105 (3), p.e87-e90

2020

Volltextzugriff (PDF)

Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment

Haematologica (Roma), 2023-12, Vol.108 (12), p.3418-3432

2023

Volltextzugriff (PDF)

Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy

Haematologica (Roma), 2015-10, Vol.100 (10), p.1275-1284

2015

Volltextzugriff (PDF)

Publisher Correction: Gene expression changes in sickle cell reticulocytes and their clinical associations

Scientific reports, 2023-09, Vol.13 (1), p.15225-2, Article 15225

2023

Volltextzugriff (PDF)

Gene expression changes in sickle cell reticulocytes and their clinical associations

Scientific reports, 2023-08, Vol.13 (1), p.12864-11, Article 12864

2023

Volltextzugriff (PDF)

Antimicrobial resistance is a risk factor for mortality in adults with sickle cell disease

Haematologica (Roma), 2021-06, Vol.106 (6), p.1745-1748

2021

Volltextzugriff (PDF)

Serum albumin is independently associated with higher mortality in adult sickle cell patients: Results of three independent cohorts

PloS one, 2020-08, Vol.15 (8), p.e0237543-e0237543

2020

Volltextzugriff (PDF)

Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a “humanized” G6PD A- mouse model

PloS one, 2020-10, Vol.15 (10), p.e0240266

2020

Volltextzugriff (PDF)

Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry

Orphanet journal of rare diseases, 2020-07, Vol.15 (1), p.178-178, Article 178

2020

Volltextzugriff (PDF)

APOL1, α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia

Haematologica (Roma), 2017-01, Vol.102 (1), p.e1-e6

2017

Volltextzugriff (PDF)

Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease

Haematologica (Roma), 2020-10, Vol.105 (10), p.2407-2419

2020

Volltextzugriff (PDF)

Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry

BMC health services research, 2024-03, Vol.24 (1), p.291-13, Article 291

2024

Volltextzugriff (PDF)

1 – 25 von 620

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(599)
Mit Volltextzugriff
(559)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(320)
Life Sciences & Biomedicine
(305)
Humans
(283)
Hematology
(168)
Female
(167)
Male
(164)
Adult
(144)
Biological And Medical Sciences
(103)
Medical Sciences
(98)
Sickle Cell Disease
(94)
Middle Aged
(91)
Anemia, Sickle Cell - Complications
(57)
Adolescent
(44)
Child
(43)
Sickle Cell Anemia
(42)
Animals
(40)
Aged
(38)
Risk Factors
(38)
Mutation
(36)
Young Adult
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

Pathophysiology and treatment of pulmonary hypertension in sickle cell disease

Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis

Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis

Erythrocytic ferroportin reduces intracellular iron accumulation, hemolysis, and malaria risk

Prevalence of iron deficiency in 62,685 women of seven race/ethnicity groups: The HEIRS Study

The Effect of the Host's Iron Status on Tuberculosis

An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease

Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease

Glad tidings and joy for children with SCA

Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom

Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia

Thrombotic risk in congenital erythrocytosis due to up-regulated hypoxia sensing is not associated with elevated hematocrit

Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment

Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy

Publisher Correction: Gene expression changes in sickle cell reticulocytes and their clinical associations

Gene expression changes in sickle cell reticulocytes and their clinical associations

Antimicrobial resistance is a risk factor for mortality in adults with sickle cell disease

Serum albumin is independently associated with higher mortality in adult sickle cell patients: Results of three independent cohorts

Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a “humanized” G6PD A- mouse model

Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry

APOL1, α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia

Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease

Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry

Suchergebnisse filtern